QA: Dynavax Technologies CORP in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001029142_2018_Dynavax_Technologies_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001029142, Dynavax Technologies CORP

  xvar xval
0 AssetsCurrent 198,023,000
1 IntangibleAssetsNetIncludingGoodwill 2,244,000
2 PropertyPlantAndEquipmentNet 16,619,000
3 remainder_Assets 1,899,000
4 LiabilitiesCurrent 18,593,000
5 LiabilitiesNoncurrent 643,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 26,447,028
9 ResearchAndDevelopmentExpense 64,650,966
10 remainder_Expenses 3,281,317
11 remainder_Revenues 4,395,936
12 remainder_NetIncome -507
13 remainder_ComprehensiveNetIncome 4,550,324
  yvar yval
0 Assets 218,785,000
1 Liabilities 19,236,000
2 Expenses 94,379,311
3 Revenues 4,395,936
4 StockholdersEquity 199,549,000
5 NetIncome -89,983,882
6 ComprehensiveNetIncome -87,708,720
7 BaseVar 170,673,539
8 EconomicCapitalRatiobeforeLimitedLiability 2.92
9 EconomicCapitalRatio 3.63

Edgar->Model Mapping

Feature Distribution

Change over Time